Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Index funds offer broad diversification with low costs, making it easier to spread risk and achieve steady market participation.
18,554 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Signet Jewelers has shown momentum, but timing the entry is tricky. This guide breaks down fundamentals, market dynam...
If you’re searching for a medical-device stock you can own for decades, Medtronic stands out. This article breaks dow...
A major manager disclosed a sizable stake reduction in BXP, prompting questions about the outlook for Class A office ...
March 2026 brings tighter rules and sharper competition among binary options platforms. This report identifies the be...
Global markets surged after President Trump hinted at de-escalation in Iran, easing oil risks and boosting equities. ...
A broader AI software sell-off created a rare opportunity for long-term investors. Here are three blue-chip options t...
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A Gulf-region conflict, surging oil prices, and a payroll standoff for TSA workers collide with spring travel demand,...
A lingering story can ride beside your finances like a 'ghost passenger seat: reality.' This article explores how nar...
Oil markets swing, but some investors seek steady income through pipeline stocks paying a 7.3% dividend. This guide e...
In a bold move, Solv Protocol plans to dump its LayerZero-backed tokenized Bitcoin tech and migrate to Chainlink. Thi...